Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
STLN holding history
Starling Oncology, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
STLN overviewAll 13F holders of STLNFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −15,642−100.0% | Sold out | Holders |
| Q3 2024 | 15,642 | $5.11K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 15,642 | $7.20K | <0.1% | −15,368−49.6% | Reduced | Holders |
| Q1 2024 | 31,010 | $49.0K | <0.1% | +14,558+88.5% | Added | Holders |
| Q4 2023 | 16,452 | $33.6K | <0.1% | −4,849−22.8% | Reduced | Holders |
| Q3 2023 | 21,301 | $29.8K | <0.1% | −49,217−69.8% | Reduced | Holders |
| Q2 2023 | 70,518 | $38.8K | <0.1% | +70,518 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −37,850−100.0% | Sold out | Holders |
| Q1 2022 | 37,850 | $270.0K | <0.1% | +19,162+102.5% | Added | Holders |
| Q4 2021 | 18,688 | $182.0K | <0.1% | +18,688 | New | Holders |